Hims & Hers Health (NYSE:HIMS) shares were on a massive run, but that momentum hit a wall recently. Since its peak on ...

Hims & Hers Health (HIMS) has disclosed plans to shut down Apostrophe, its acne treatment business. This change is part of ...

Roller-coaster healthcare stock Hims & Hers Health (NYSE: HIMS), whose stock got devastated last week by worries that it ...

Hims & Hers (NYSE: HIMS) is taking investors on a roller-coaster ride in 2025. Where to invest $1,000 right now? Our analyst ...

In other words, while Hims & Hers' tirzepatide business is going away ... On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they ...

For investors and stakeholders in Hims & Hers, the FDA's decision offers some regulatory certainty in the near term. The company's stock performance will continue to be influenced by its ability ...

Learn More » *Stock prices used were the afternoon prices of March 6, 2025. The video was published on March 8, 2025. Should you invest $1,000 in Hims & Hers Health right now? Before you buy ...

(This section is what permits Hims & Hers to produce otherwise patent-protected GLP-1 drugs while the supply of such drugs is in deficit.) As regards semaglutide, FDA says compounders such as Hims ...

Hims & Hers(NYSE: HIMS) stock is down 50% from its peak earlier this year, but the drop in shares hasn't been driven by deteriorating operations. In fact, the company is growing as fast as ever.